General and Pancreatic Surgery Department, Pancreas Institute, University and Hospital Trust of Verona, Verona, Italy.
Gastroenterology and Digestive Endoscopy Unit, Pancreas Institute, University and Hospital Trust of Verona, Verona, Italy.
Dig Endosc. 2018 Nov;30(6):777-784. doi: 10.1111/den.13221. Epub 2018 Jul 26.
Implications of preoperative biliary drain on morbidity and mortality after pancreatoduodenectomy are still controversial. The present study aims to assess the impact of preoperative biliary drain on postoperative outcome and to define optimal serum bilirubin cut-off to recommend biliary drainage in patients undergoing pancreatoduodenectomy.
All consecutive pancreatoduodenectomies carried out at Verona Hospital from 2005 to 2016 were retrospectively analyzed. The study population was divided into three groups: preoperative biliary drained (Stented Group), preoperative jaundice without drainage (Jaundiced Group) and the control group of non-jaundiced, non-stented patients (Control Group).
A total of 1500 patients were included. Seven hundred and fourteen patients (47.6%) received biliary drain (stented group), 258 (17.2%) patients did not (jaundiced group) and 528 (35.2%) patients represented the (control group). Major complications and mortality rates did not differ between groups. Conversely, the risk of developing surgical site infections doubled in the stented group (18.1%) (OR = 2.1, 95% CI = 1.5-2.8). In jaundiced patients, a preoperative bilirubin value greater than 7.5 mg/dL (128 μmol/L) accurately predicted the likelihood of postoperative complications.
Preoperative biliary drain does not increase major complications and mortality rates after pancreatoduodenectomy, but it is associated with higher surgical site infection rates. In jaundiced patients, a bilirubin value greater than 7.5 mg/dL (128 μmol/L) should indicate biliary drainage.
术前胆道引流对胰十二指肠切除术后发病率和死亡率的影响仍存在争议。本研究旨在评估术前胆道引流对术后结果的影响,并确定最佳血清胆红素截断值,以推荐在接受胰十二指肠切除术的患者中进行胆道引流。
回顾性分析了 2005 年至 2016 年在维罗纳医院进行的所有连续胰十二指肠切除术。研究人群分为三组:术前胆道引流(支架组)、术前无引流性黄疸(黄疸组)和非黄疸、非支架患者的对照组(对照组)。
共纳入 1500 例患者。714 例(47.6%)接受胆道引流(支架组),258 例(17.2%)未接受引流(黄疸组),528 例(35.2%)为对照组。各组之间主要并发症和死亡率无差异。相反,支架组发生手术部位感染的风险增加了一倍(18.1%)(OR = 2.1,95%CI = 1.5-2.8)。在黄疸患者中,术前胆红素值大于 7.5mg/dL(128μmol/L)准确预测了术后并发症的可能性。
术前胆道引流不会增加胰十二指肠切除术后的主要并发症和死亡率,但与更高的手术部位感染率相关。在黄疸患者中,胆红素值大于 7.5mg/dL(128μmol/L)应提示进行胆道引流。